Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announced the appointment of Stéphane Thiroloix to the position of President, Europe Advanced Surgical Devices Division (ASD). He will be based in Baar, Switzerland and will report to Mike Frazzette, President, ASD, and will serve as a member of the Division’s Executive Team.
Stéphane will be responsible for leading and directing all commercial activities in ASD’s European markets focused on the Orthopaedics and Sports Medicine product portfolios.
Stéphane graduated from the Ecole des Hautes Etudes Commerciales (HEC) in France in 1986. After joining Roussel Uclaf (which became Hoechst Marion Roussel, then Aventis and now Sanofi), he held various executive positions in France, South Africa, Mexico and Australia, ultimately as General Manager. He later joined SmithKline Beecham as VP and Sales Director of French Operations, and moved on to become VP and Director of Operations, and ultimately VP of European Business Development and Marketing Alliances within GlaxoSmithKline. He joined Bristol-Myers Squibb in 2002 as VP of French Operations and was promoted to VP Europe and General Manager France in 2004. Until recently, he was Executive VP of Corporate Development at Ipsen, a global biopharmaceutical company headquartered in France.
“We’re excited to have Stéphane join our European team,” Frazzette stated. “His operational experience and commercial- and customer-focused approach will enable Smith & Nephew to better serve the needs of our diverse customer base and develop competitive advantages for our business.”
Source: Smith and Nephew